Dehydration and Your Kidneys on a GLP-1

What the warning actually says

Every one of these medicines carries a numbered warning about your kidneys. It is worth reading closely, because it is not what most people assume.

The Wegovy label reports cases of acute kidney injury after the drug went on sale. Some of them needed dialysis. Then it says the important part: most of those cases happened in people who got dehydrated from nausea, vomiting or diarrhea¹. Zepbound's label says the same thing, almost word for word².

So the drug is not attacking your kidneys. What happens is simpler. You feel sick. You cannot keep fluids down, or you have diarrhea for days. You lose more water than you take in. Kidneys do badly without enough fluid.

That matters, because it means this risk is mostly preventable. A side effect you can act on is very different from one you cannot.

When it is most likely

Both labels name the same window: when you start, and when your dose goes up^1,2. Those are the weeks when nausea and vomiting are worst.

Both also tell your clinician to check kidney function if you report symptoms that could dry you out^1,2. That is a real instruction, and you are allowed to ask for it.

Why it is easy to miss

Two things make this sneak up on mothers in particular.

The first is that thirst drops with appetite. These drugs quiet the signal that tells you to eat, and many women find the signal to drink goes quiet too. You are not ignoring thirst. You are not feeling it.

The second is that early dehydration feels like ordinary tiredness. Being exhausted at the end of a long day with children is normal. That is exactly why nobody thinks about their kidneys.

The other half of the story

Here is where it gets interesting, and where you should be careful with what you read.

A large trial published in 2024 followed 3,533 people with type 2 diabetes and existing chronic kidney disease for a median of 3.4 years. Half took semaglutide, half took placebo. The people on semaglutide had 24% fewer kidney failure and death events — a hazard ratio of 0.76³. Looking only at the kidney outcomes, the figure was 0.79. Deaths from heart causes fell too, at 0.71³. The trial was stopped early because the benefit was clear.

Now the caveat, and it is the most important sentence on this page. Everyone in that trial already had type 2 diabetes and kidney disease. The result does not say these drugs protect healthy kidneys. It says that in people whose kidneys were already failing, semaglutide slowed it down.

If you are a healthy mother taking this to lose weight, that trial is not about you. What applies to you is the dehydration warning above.

Both things are true at once. Over years, in sick kidneys, the drug helps. Over a bad week of vomiting, dehydration can hurt them. Different timescale, different mechanism, different people.

What to do

• Drink on a schedule, not on thirst. Thirst is not reliable on this medicine. A bottle you refill at fixed points in the day works better than waiting to feel it.
• Treat a bad episode as a real event. A day of vomiting or several days of diarrhea is when this happens. Call, do not wait it out.
• Ask for a kidney check if you have had a rough stretch, especially after starting or increasing a dose. It is an ordinary blood test.
• Be careful in heat. Summer, a fever, or a stomach bug on top of the medicine stack up.

When to seek care the same day

• You cannot keep fluids down at all
• You are passing much less urine than usual, or none
• You feel dizzy when you stand, or your heart is racing
• You are confused, or unusually drowsy

One more practical point. Neither drug needs a dose change if your kidneys are impaired — Zepbound's label states that no adjustment is recommended, and that its levels did not change even in people on dialysis². Existing kidney trouble is not automatically a reason you cannot take this. It is a reason to be watched more closely.

This page is information, not medical advice. Take these questions to your own clinician.